Osteoporosis

>

Latest News

Fracture risk reduction greater with denosumab vs alendronate osteoporotic femur image © Crevis/Adobe Stock
Denosumab Superior to Alendronate for Reduction of Postmenopausal Fracture Risk in Real-world Study

May 10th 2023

Denosumab reduced RR of fracture vs alendronate across fracture types, eg, by 36% for hip fracture, by 43% for nonvertebral fractures, and by 30% for vertebral fractures.

Weekly primary care research update
Friday's 5 Quotes for Primary Care 5-5-2023

May 5th 2023

Oral Superabsorbent Hydrogel Cuts Risk for Type 2 Diabetes
Daily Dose: Weight Loss Surgery & Bone Health in Adolescents

April 25th 2023

Weight Loss Surgery May Compromise Bone Density and Strength in Adolescents, Young Adults Bone loss image ©Crevis/Shutterstock
Weight Loss Surgery May Compromise Bone Density and Strength in Adolescents, Young Adults

April 24th 2023

Oral Superabsorbent Hydrogel Cuts Risk for Type 2 Diabetes
Daily Dose: Impact of Air Pollution on Bone Mineral Density in Women

March 3rd 2023

More News

© 2023 MJH Life Sciences

All rights reserved.